Solving the Facility Challenge Powering the Next Wave of Nuclear Medicine
Thursday July 16 | 12pm ET
Radiopharmaceuticals and nuclear medicine are entering a period of rapid growth, fueled by scientific innovation, significant investment, and an urgent patient mandate. But scaling this industry requires more than breakthrough science — it demands highly specialized facilities, careful site selection, and complex execution.
In this live webinar, industry and real estate leaders will explore the evolving radiopharmaceutical landscape, the unique challenges of siting and developing next‑generation facilities, and how these considerations are shaping real estate demand nationwide. Featuring insights from Sumit Verma, CEO of Orchestra Life Sciences, alongside JLL subject matter experts, the discussion will highlight a real‑world example of how a rapidly growing company evaluated hundreds of sites before selecting the Bellwether District in Philadelphia.
Whether you are a biotech or pharma executive, investor, or operator, this session will provide practical insight into what it takes to successfully deliver radiopharmaceutical facilities at scale — and how strategic real estate decisions can accelerate growth in this emerging sector.
- Overview of the radiopharmaceutical and nuclear medicine landscape, including key growth drivers and market momentum
- Perspective on the patient mandate and how it is shaping industry urgency and investment
- Insights into the complexities of siting and developing radiopharmaceutical facilities, including regulatory, infrastructure, and operational considerations
- Discussion of real estate implications, including demand for specialized facilities and location decision factors
- A real‑world case study of a large-scale national site selection process evaluating hundreds of locations
- Deep dive into the Bellwether District in Philadelphia as a purpose-built solution supporting radiopharmaceutical growth
- Practical considerations for aligning real estate strategy with industry-specific challenges and timelines
- Live Q&A with industry and real estate experts